These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 38982864)
21. The cGAS-STING Pathway: Novel Perspectives in Liver Diseases. Xu D; Tian Y; Xia Q; Ke B Front Immunol; 2021; 12():682736. PubMed ID: 33995425 [TBL] [Abstract][Full Text] [Related]
22. Mitochondrial DNA Programs Lactylation of cGAS to Induce IFN Responses in Patients with Systemic Lupus Erythematosus. Zhang J; Ji H; Liu M; Zheng M; Wen Z; Shen H J Immunol; 2024 Sep; 213(6):795-807. PubMed ID: 39093026 [TBL] [Abstract][Full Text] [Related]
23. Beyond DNA sensing: expanding the role of cGAS/STING in immunity and diseases. Seok JK; Kim M; Kang HC; Cho YY; Lee HS; Lee JY Arch Pharm Res; 2023 Jun; 46(6):500-534. PubMed ID: 37354378 [TBL] [Abstract][Full Text] [Related]
24. UXT attenuates the CGAS-STING1 signaling by targeting STING1 for autophagic degradation. Pan M; Yin Y; Hu T; Wang X; Jia T; Sun J; Wang Q; Meng W; Zhu J; Dai C; Hu H; Wang C Autophagy; 2023 Feb; 19(2):440-456. PubMed ID: 35543189 [TBL] [Abstract][Full Text] [Related]
25. Cyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase (cGAS), a Multifaceted Platform of Intracellular DNA Sensing. Verrier ER; Langevin C Front Immunol; 2021; 12():637399. PubMed ID: 33708225 [TBL] [Abstract][Full Text] [Related]
26. Structures and Mechanisms in the cGAS-STING Innate Immunity Pathway. Zhang X; Bai XC; Chen ZJ Immunity; 2020 Jul; 53(1):43-53. PubMed ID: 32668227 [TBL] [Abstract][Full Text] [Related]
27. Emerging role of the cGAS-STING signaling pathway in autoimmune diseases: Biologic function, mechanisms and clinical prospection. Hu Y; Chen B; Yang F; Su Y; Yang D; Yao Y; Wang S; Wu Y; Tao L; Xu T Autoimmun Rev; 2022 Sep; 21(9):103155. PubMed ID: 35902046 [TBL] [Abstract][Full Text] [Related]
28. cGAS-STING signaling pathway in gastrointestinal inflammatory disease and cancers. Ke X; Hu T; Jiang M FASEB J; 2022 Jan; 36(1):e22029. PubMed ID: 34907606 [TBL] [Abstract][Full Text] [Related]
29. cGAS-STING signaling in cardiovascular diseases. Zhang Q; Shen L; Ruan H; Huang Z Front Immunol; 2024; 15():1402817. PubMed ID: 38803502 [TBL] [Abstract][Full Text] [Related]
30. Activation of the cGAS-STING innate immune response in cells with deficient mitochondrial topoisomerase TOP1MT. Al Khatib I; Deng J; Lei Y; Torres-Odio S; Rojas GR; Newman LE; Chung BK; Symes A; Zhang H; Huang SN; Pommier Y; Khan A; Shadel GS; West AP; Gibson WT; Shutt TE Hum Mol Genet; 2023 Jul; 32(15):2422-2440. PubMed ID: 37129502 [TBL] [Abstract][Full Text] [Related]
31. The cGAS-STING Pathway: A Ubiquitous Checkpoint Perturbing Myocardial Attributes. Wan X; Tian J; Hao P; Zhang J; Zhou Y; Ge C; Song X Curr Vasc Pharmacol; 2023; 21(3):152-162. PubMed ID: 37138486 [TBL] [Abstract][Full Text] [Related]
32. Post-Translational Modifications of cGAS-STING: A Critical Switch for Immune Regulation. Yu Y; Liu J; Liu C; Liu R; Liu L; Yu Z; Zhuang J; Sun C Cells; 2022 Sep; 11(19):. PubMed ID: 36231006 [TBL] [Abstract][Full Text] [Related]
33. Pseudorabies virus usurps non-muscle myosin heavy chain IIA to dampen viral DNA recognition by cGAS for antagonism of host antiviral innate immunity. Liu Y; Qin Y; Yang B; Zheng H; Qiao S; Luo Z; Li R J Virol; 2024 May; 98(5):e0048324. PubMed ID: 38639486 [TBL] [Abstract][Full Text] [Related]
34. Role of the cGAS-STING pathway in cancer development and oncotherapeutic approaches. Khoo LT; Chen LY EMBO Rep; 2018 Dec; 19(12):. PubMed ID: 30446584 [TBL] [Abstract][Full Text] [Related]
35. Radiotherapy and cGAS/STING signaling: Impact on MDSCs in the tumor microenvironment. Kho VM; Mekers VE; Span PN; Bussink J; Adema GJ Cell Immunol; 2021 Apr; 362():104298. PubMed ID: 33592541 [TBL] [Abstract][Full Text] [Related]
36. The cGAS-STING pathway: Post-translational modifications and functional implications in diseases. Liu J; Rui K; Peng N; Luo H; Zhu B; Zuo X; Lu L; Chen J; Tian J Cytokine Growth Factor Rev; 2022 Dec; 68():69-80. PubMed ID: 36151014 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of mTOR suppresses IFNα production and the STING pathway in monocytes from systemic lupus erythematosus patients. Murayama G; Chiba A; Kuga T; Makiyama A; Yamaji K; Tamura N; Miyake S Rheumatology (Oxford); 2020 Oct; 59(10):2992-3002. PubMed ID: 32160289 [TBL] [Abstract][Full Text] [Related]
38. The cGAS-STING pathway drives type I IFN immunopathology in COVID-19. Domizio JD; Gulen MF; Saidoune F; Thacker VV; Yatim A; Sharma K; Nass T; Guenova E; Schaller M; Conrad C; Goepfert C; de Leval L; Garnier CV; Berezowska S; Dubois A; Gilliet M; Ablasser A Nature; 2022 Mar; 603(7899):145-151. PubMed ID: 35045565 [TBL] [Abstract][Full Text] [Related]
39. cGAS-STING pathway mediates activation of dendritic cell sensing of immunogenic tumors. Li G; Zhao X; Zheng Z; Zhang H; Wu Y; Shen Y; Chen Q Cell Mol Life Sci; 2024 Mar; 81(1):149. PubMed ID: 38512518 [TBL] [Abstract][Full Text] [Related]